Track topics on Twitter Track topics that are important to you
7575 W. 103rd Avenue, Suite 102
United States of America
AMB-220-E is an international, multicenter, open-label study examining the long-term safety of ambrisentan (BSF 208075) in subjects who have previously completed Myogen study AMB-220, "A P...
Myogen is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapeutics for the treatment of cardiovascular disorders. We believe that our adva...
Research and development of therapeutics based on signaling pathways in cardiac, hypertrophy, myosin heavy chain research and gene/protein expression profiling using its human cardiac tissue bank.
We have published hundreds of Myogen, Inc. news stories on BioPortfolio along with dozens of Myogen, Inc. Clinical Trials and PubMed Articles about Myogen, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Myogen, Inc. Companies in our database. You can also find out about relevant Myogen, Inc. Drugs and Medications on this site too.
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...
Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...